Health ❯Healthcare ❯Neurology

Cognitive Disorders

Dementia Alzheimer's Disease Parkinson's Disease Schizophrenia Alzheimer's Disease Treatments Amyloid Plaques in Alzheimer's Dementia Risk Factors Memory Loss All-cause Dementia Mild Cognitive Impairment Dementia Management

Leqembi Approved by European Regulators for Early-Stage Alzheimer's Treatment

The decision overturns an initial rejection, confirming the drug's efficacy in slowing cognitive decline while addressing safety concerns.

New Study Links Diabetes Drug Class to 45% Lower Dementia Risk

GLP-1 Drugs Like Ozempic Linked to Lower Dementia Risk in New Studies

House Republicans to Investigate Alleged Cover-Up of Biden’s Cognitive Decline

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

Study Links Common Medications to Reduced Dementia Risk

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline

New Blood Tests Enhance Alzheimer's Diagnosis Accuracy